Pfizer to Acquire InnoPharma|
Wednesday, July 16, 2014
Under the terms of the agreement, Pfizer will acquire InnoPharma for an upfront cash payment of $225 million, with up to $135 million of contingent milestone payments.
First Drug Candidate from NIH Program Acquired by Baxter
Tuesday, July 15, 2014
Potential treatment targets sickle cell disease.
CloudScientific Appointed as Cresset’s Distributor in China
Friday, July 11, 2014
CloudScientific appointed as distributor of computational chemistry software.
Waters, Chinese Pharmacopeia Commission Establish Joint Open Laboratory
Thursday, July 10, 2014
Located in the laboratory building of Beijing Zhendong Guangming Drug Research Institute, the new facility is over 400m2.
Evotec, Fraunhofer in Drug Discovery Collaboration
Tuesday, July 08, 2014
The exclusive, strategic collaboration will combine the relevant platforms of both organisations, focusing on several disease areas.
Isis Pharmaceuticals Earns $1 Million from GSK
Thursday, July 03, 2014
Advances HBV development program to develop antisense drugs.
SP Industries Acquires Bel-Art Products
Wednesday, July 02, 2014
Through this acquisition, SP adds to its portfolio over 3,500 additional products sold under Bel-Art’s flagship Scienceware and H-B Instrument brand names.
AMRI Completes OsoBio Acquisition
Tuesday, July 01, 2014
Oso Biopharmaceuticals is recognized as a premier contract manufacturer of highly complex injectable drug products.
Endo to Acquire DAVA Pharmaceuticals
Thursday, June 26, 2014
The acquisition enhances Endo's commercialization and development platform and is expected to be immediately accretive to company's 2014 adjusted earnings per share.